Krka Reports Fall in Nine-Month Profit

Ljubljana, 17 November - Pharmaceutical group Krka posted a net profit of EUR 115.4m in the first nine months of 2011, which is 4% less than in the same period last year, while the core company's net profit dropped by 17.3% to EUR 109.2m. The company is planning to list its shares on the Warsaw Stock Exchange by June 2012.

Novo mesto The management of pharmaceutical company Krka presenting the nine-month results. Photo: Rasto Bozic/STA

Novo mesto
The management of pharmaceutical company Krka presenting the nine-month results.
Photo: Rasto Bozic/STA

Novo mesto The management of pharmaceutical company Krka presenting the nine-month results. Photo: Rasto Bozic/STA

Novo mesto
The management of pharmaceutical company Krka presenting the nine-month results.
Photo: Rasto Bozic/STA

Novo mesto Krka chairman Joze Colaric presenting the nine-month results of the pharmaceutical company. Photo: Rasto Bozic/STA

Novo mesto
Krka chairman Joze Colaric presenting the nine-month results of the pharmaceutical company.
Photo: Rasto Bozic/STA

The rest of this news item is available to subscribers.
The news item consists of 839 characters (without spaces) or 174 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

zm/ep
© STA, 2011